{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-019370","form_type":"8-K","ticker":"BFRI","cik":"0001858685","company_name":"Biofrontera Inc.","filed_at":"2025-10-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.845623+00:00","generated_at":"2026-05-17T02:22:07.518241+00:00","sec_items":["1.01","2.01","3.02","8.01","5.03","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Biofrontera closes acquisition of U.S. rights to Ameluz; raises $2.5M in Series C preferred","bullets":["Acquired all U.S. rights to Ameluz and RhodoLED from former parent Biofrontera AG per Asset Purchase Agreement dated Oct 20, 2025.","Earnout replaces prior transfer pricing model: 12% of U.S. net sales ≤$65M, 15% if >$65M.","Closed second tranche of Series C Preferred Stock, raising $2.5M gross; total offering now $11M.","Believes stockholders' equity now exceeds $5M, regaining compliance with Nasdaq minimum equity requirement.","Proceeds from preferred stock to fund acquisition and transfer costs and general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-019370","json":"https://secwatch.observer/filing/0001493152-25-019370.json","markdown":"https://secwatch.observer/filing/0001493152-25-019370.md","text":"https://secwatch.observer/filing/0001493152-25-019370.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1858685/000149315225019370/0001493152-25-019370-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1858685/000149315225019370/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T02:22:07.518241+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}